138 related articles for article (PubMed ID: 4574770)
1. Immunological associations of the halo naevus with cutaneous malignant melanoma.
Copeman PW; Lewis MG; Phillips TM; Elliott PG
Br J Dermatol; 1973 Feb; 88(2):127-37. PubMed ID: 4574770
[No Abstract] [Full Text] [Related]
2. The halo naevus and malignant melanoma.
Lancet; 1973 May; 1(7810):982. PubMed ID: 4121601
[No Abstract] [Full Text] [Related]
3. Melanoma specific protein: occurrence in the urine of patients with halo naevus and vitiligo.
Cooke KB; Bennett C; Staughton RC
Br J Dermatol; 1978 Jun; 98(6):663-8. PubMed ID: 678452
[TBL] [Abstract][Full Text] [Related]
4. Halo nevus: competent surveillance of potential melanoma?
Krebs JA; Roenigk HH; Deodhar SD; Barna B
Cleve Clin Q; 1976; 43(1):11-5. PubMed ID: 1261030
[No Abstract] [Full Text] [Related]
5. Letter: The halo naevus and cutaneous malignant melanoma.
Whimster IW
Br J Dermatol; 1974 Jan; 90(1):111-3. PubMed ID: 4811833
[No Abstract] [Full Text] [Related]
6. Melanoma cytoplasmic humoral antibody test. A diagnostic adjunct.
Copeman PW; Elliott PG
Br J Dermatol; 1976 May; 94(5):565-8. PubMed ID: 773408
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous onset of segmental vitiligo and a halo surrounding a congenital melanocytic naevus.
Hofmann UB; Bröcker EB; Hamm H
Acta Derm Venereol; 2009; 89(4):402-6. PubMed ID: 19688155
[TBL] [Abstract][Full Text] [Related]
8. Melanocyte mutation in halo naevus and malignant melanoma?
Bennett C; Copeman PW
Br J Dermatol; 1979 Apr; 100(4):423-6. PubMed ID: 378250
[TBL] [Abstract][Full Text] [Related]
9. Vitiligo and malignant melanoma: a significant association?
Gregor RT
S Afr Med J; 1976 Aug; 50(3F):1447-9. PubMed ID: 973163
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cell-mediated immunity to melanoma cells in patients with vitiligo, halo nevi or melanoma.
Mitchell MS; Nordlund JJ; Lerner AB
J Invest Dermatol; 1980 Aug; 75(2):144-7. PubMed ID: 7410884
[No Abstract] [Full Text] [Related]
11. Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma.
Hellström I; Warner GA; Hellström KE; Sjögren HO
Int J Cancer; 1973 Mar; 11(2):280-92. PubMed ID: 4790696
[No Abstract] [Full Text] [Related]
12. Halo naevus--a frustrated malignant maelanoma.
Lewis MG; Copeman PW
Br Med J; 1972 Apr; 2(5804):47-8. PubMed ID: 4552592
[No Abstract] [Full Text] [Related]
13. Halo congenital nevus undergoing spontaneous regression. Involvement of T-cell immunity in involution and presence of circulating anti-nevus cell IgM antibodies.
Tokura Y; Yamanaka K; Wakita H; Kurokawa S; Horiguchi D; Usui A; Sayama S; Takigawa M
Arch Dermatol; 1994 Aug; 130(8):1036-41. PubMed ID: 8053701
[TBL] [Abstract][Full Text] [Related]
14. Differentiation between B cells, T cells, and histiocytes in melanocytic lesions: primary and metastatic melanoma and halo and giant pigmented nevi.
Edelson RL; Hearing VJ; Dellon AL; Frank M; Edelson EK; Green I
Clin Immunol Immunopathol; 1975 Nov; 4(4):557-68. PubMed ID: 1081937
[No Abstract] [Full Text] [Related]
15. Halo dermatitis followed by the development of vitiligo associated with Sutton's nevi.
Brandt O; Christophers E; Fölster-Holst R
J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S101-4. PubMed ID: 15858503
[TBL] [Abstract][Full Text] [Related]
16. Immunofluorescent detection of antibodies to ocular melanomas.
Wong IG; Oskvig RM
Arch Ophthalmol; 1974 Aug; 92(2):98-102. PubMed ID: 4136249
[No Abstract] [Full Text] [Related]
17. Fibrosis in regressing melanoma versus nonfibrosis in halo nevus upon melanocyte disappearance: could it be related to a different cytokine microenvironment?
Moretti S; Spallanzani A; Pinzi C; Prignano F; Fabbri P
J Cutan Pathol; 2007 Apr; 34(4):301-8. PubMed ID: 17381800
[TBL] [Abstract][Full Text] [Related]
18. [Immunohistologic detection of bullous pemphigoid antigen in malignant melanoma].
Hamm G; Reiss CJ
Dermatol Monatsschr; 1985; 171(12):788-92. PubMed ID: 3912222
[No Abstract] [Full Text] [Related]
19. The immune response in halo nevi.
Zeff RA; Freitag A; Grin CM; Grant-Kels JM
J Am Acad Dermatol; 1997 Oct; 37(4):620-4. PubMed ID: 9344203
[TBL] [Abstract][Full Text] [Related]
20. [Delayed hypersensitivity reaction in malignant melanoma].
Gorodilova VV; Saraeva ZM; Slesareva RI; Monzul' GD
Vopr Onkol; 1973; 19(3):23-7. PubMed ID: 4762691
[No Abstract] [Full Text] [Related]
[Next] [New Search]
